PainChek

PainChek P/TBV

The Price to Tangible Book Value (P/TBV) of PainChek (PCK.AX) as of Nov 11, 2026 is -24.07. In the previous year, Price to Tangible Book Value (P/TBV) was -30.99 — a change of -22.31% (higher).

P/TBV

-24.07

YoY

-22.31%

Last updated:

Price to Tangible Book Value (P/TBV) of PainChek is 2026 -24.07 . Price to Tangible Book Value (P/TBV) of PainChek was 2025 -30.99 . It decreases by -22.31% higher compared to the previous year.

The PainChek P/TBV history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/TBV
Date
P/TBV
Jan 1, 2019
8.37 AUD
Jan 1, 2020
8.35 AUD
Jan 1, 2021
4.18 AUD
Jan 1, 2022
7.15 AUD
Jan 1, 2023
51.62 AUD
Jan 1, 2024
26.73 AUD
Jan 1, 2025
-30.99 AUD
Jan 1, 2026
-24.07 AUD
The PainChek P/TBV history
YEARP/TBVYoY
-24.07-22.31%
-30.99-215.94%
26.73-48.22%
51.62+621.93%
7.15+70.92%
4.18-49.92%
8.35-0.18%
8.37-21.75%
10.69-23.01%
13.89-136.85%
-37.70-261.43%
23.35-45.55%
42.89—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PainChek Stock analysis

What does PainChek do? PainChek Ltd. develops and commercializes mobile medical device applications, focusing on pain assessment for individuals unable to communicate with carers. The PainChek Universal combines the PainChek Application with the numerical rating scale (NRS), using artificial intelligence and facial recognition to detect pain in non-verbal patients. It provides a point-of-care solution that offers objectivity and consistency in pain assessments, supporting both non-verbal and self-reporting individuals through integrated tools. Healthcare providers and care facilities purchase PainChek Universal to enhance pain management protocols for patients with communication difficulties. The PainChek Application utilizes artificial intelligence and facial recognition technology to assess pain without relying on patient self-reporting, making it suitable for those with cognitive or physical impairments. PainChek Universal integrates the NRS for patients who can self-report, ensuring a comprehensive approach to pain evaluation across varying patient capabilities. This dual functionality allows healthcare professionals to apply consistent assessment standards regardless of a patient's ability to communicate. PainChek Ltd. generates revenue through the commercialization of its mobile medical device applications, specifically targeting healthcare providers and care facilities that require standardized pain assessment tools. The company’s products are designed to address the needs of patients who cannot communicate pain, thereby filling a critical gap in healthcare services. By offering a unified solution that combines AI-driven detection with traditional rating scales, PainChek Universal meets the demands of modern healthcare environments seeking objective and reliable pain management solutions. PainChek is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PainChek stock

Price to Tangible Book Value (P/TBV) of PainChek is -24.07 in 2026.

Price to Tangible Book Value (P/TBV) of PainChek changed from -30.99 to -24.07, representing a -22.31% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Price to Tangible Book Value (P/TBV) PainChek since 2006 – with annual values, charts, and detailed analysis.

P/TBV compares the stock price to tangible book value per share, excluding goodwill and intangibles. It provides a conservative asset-based valuation.

To evaluate Price to Tangible Book Value (P/TBV)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Price to Tangible Book Value (P/TBV).

A 'good' varies by industry and company stage. On Eulerpool, you can compare Price to Tangible Book Value (P/TBV)'s PainChek with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — PainChek

All Key Metrics — PainChek